EcoR1 Capital as of Dec. 31, 2017
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 30 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Assembly Biosciences | 15.0 | $133M | 2.9M | 45.25 | |
| Fibrogen (FGEN) | 10.9 | $97M | 2.0M | 47.40 | |
| Celgene Corp option | 10.3 | $91M | 875k | 104.36 | |
| Ironwood Pharmaceuticals (IRWD) | 9.9 | $88M | 5.9M | 14.99 | |
| Ascendis Pharma A S (ASND) | 9.5 | $84M | 2.1M | 40.06 | |
| Kura Oncology (KURA) | 6.5 | $58M | 3.8M | 15.30 | |
| Dicerna Pharmaceuticals | 4.9 | $44M | 4.8M | 9.03 | |
| Array BioPharma | 4.2 | $37M | 2.9M | 12.80 | |
| Wave Life Sciences (WVE) | 3.7 | $33M | 936k | 35.10 | |
| Myokardia | 3.7 | $33M | 778k | 42.10 | |
| Apellis Pharmaceuticals (APLS) | 2.8 | $25M | 1.1M | 21.70 | |
| Spark Therapeutics Inc call | 2.6 | $23M | 456k | 51.42 | |
| Macrogenics (MGNX) | 2.4 | $22M | 1.1M | 19.00 | |
| Rhythm Pharmaceuticals (RYTM) | 1.7 | $15M | 530k | 29.06 | |
| Immune Design | 1.6 | $14M | 3.6M | 3.90 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 1.5 | $14M | 3.9M | 3.50 | |
| Fibrogen | 1.5 | $14M | 285k | 47.40 | |
| Galapagos Nv- (GLPG) | 1.2 | $10M | 110k | 93.76 | |
| Beigene (BGNE) | 0.9 | $8.2M | 84k | 97.72 | |
| Ironwood Pharmaceuticals Inc cl a | 0.8 | $7.5M | 500k | 14.99 | |
| Corvus Pharmaceuticals (CRVS) | 0.7 | $6.1M | 588k | 10.36 | |
| Achillion Pharmaceuticals | 0.6 | $5.3M | 1.8M | 2.88 | |
| Kindred Biosciences | 0.6 | $5.1M | 545k | 9.45 | |
| Uniqure Nv call | 0.6 | $5.2M | 264k | 19.59 | |
| Clementia | 0.4 | $3.7M | 194k | 18.98 | |
| Madrigal Pharmaceuticals (MDGL) | 0.4 | $3.2M | 35k | 91.80 | |
| Denali Therapeutics (DNLI) | 0.3 | $3.1M | 200k | 15.64 | |
| Xencor (XNCR) | 0.3 | $2.5M | 113k | 21.92 | |
| Mirati Therapeutics | 0.2 | $1.9M | 103k | 18.25 | |
| Intellia Therapeutics Inc call | 0.2 | $1.4M | 75k | 19.23 |
